Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”

Bibliographic Details
Main Authors:	Simone Famularo, MD, Matteo Donadon, MD, PhD, Federica Cipriani, MD, Luca Aldrighetti, MD, PhD, Franco Trevisani, MD, Guido Torzilli, MD, PhD, FACS
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2023-03-01
Series:	Annals of Surgery Open
Online Access:	http://journals.lww.com/10.1097/AS9.0000000000000251

Similar Items

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
by: Xinye Qian, MD, PhD
Published: (2023-03-01)

Comment on “The Goal of Intraoperative Blood Loss in Major Hepatectomy Resection for Perihilar Cholangiocarcinoma Saving Patients From a Heavy Complication Burden”
by: Francesca Ratti, MD, et al.
Published: (2024-03-01)

Carbon Ion Radiation Therapy for Nonmetastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis
by: Yuhei Miyasaka, MD, PhD, et al.
Published: (2024-04-01)

The Effect of Microvascular Invasion on Hepatocellular Carcinoma With Portal Vein Tumor Thrombus After Hepatectomy: A Retrospective Study
by: Qingyi Xu MD, et al.
Published: (2024-06-01)

Risk Factors and Management of Portal Vein Thrombosis after Hepatectomy: A Single-Center Experience
by: Kazuki Wakizaka, MD, PhD, et al.
Published: (2024-12-01)

Successful coil embolization of post-hepatectomy arterioportal fistula that reduced ascites and improved liver function
by: Ryuta Okuhira, MD, et al.
Published: (2024-06-01)

Comment on “The Unbearable Lightness of Difference Between Statistical and Clinical Significance”
by: Yuqin Cao, MD, et al.
Published: (2022-03-01)

EUS-guided radiofrequency ablation of a hepatocellular carcinoma of the liver
by: Fabia Attili, MD, PhD, et al.
Published: (2018-05-01)

Comment on “Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma”
by: Xu Wang, MD, et al.
Published: (2024-06-01)

Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shohei Okazaki, MD, PhD, et al.
Published: (2024-04-01)

Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma
by: Yasuhito Mitsuyama, MD, et al.
Published: (2023-09-01)

Comment on “Surgical Margin of Resected Colorectal Liver Metastases: How Accurate Is Surgeon Prediction?”
by: Yoichiro Uchida, MD, PhD, et al.
Published: (2024-09-01)

Sorafenib as Adjuvant Therapy Post–Liver Transplant: A Single-center Experience
by: Hala Hassanain, MD, et al.
Published: (2025-02-01)

A rare case of hepatocellular carcinoma with bile duct invasion diagnosed by peroral cholangioscopy
by: Risako Ito, MD, et al.
Published: (2021-08-01)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
by: Yoshifumi Baba, MD, PhD, FACS, et al.
Published: (2022-03-01)

Comment on Portal Hemodynamics in Liver Transplantation: Do not Shunt The Large-For-Flow!
by: Xavier Muller, MD, PhD, et al.
Published: (2024-06-01)

Comment on The Unbearable Lightness of Difference Between Statistical and Clinical Significance
by: Luca Bertolaccini, MD, PhD, FCCP, et al.
Published: (2022-03-01)

Comment on “Long-Term Outcome of Immediate Versus Postponed Intervention in Patients With Infected Necrotizing Pancreatitis (POINTER)”: Multicenter Randomized Trial
by: Shuirong Lin, MD, et al.
Published: (2024-12-01)

Comment on: Age Matters. What Affects the Cumulative Lifespan of a Transplanted Liver?
by: Paolo De Simone, MD, PhD, et al.
Published: (2024-06-01)

Comment on “Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI Trial)”
by: Xi Yu, MD, et al.
Published: (2024-06-01)

Comment on “Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study with Propensity-Score-Matched Analysis”
by: Kojiro Taura, MD, PhD, et al.
Published: (2023-12-01)

Comment on: Textbook Outcomes Following Open Live Donor Right Hepatectomy and Open Right Hepatic Lobectomy for Cancer in 686 Patients: Re-Defining the Benchmark
by: Zhi-Peng Liu, MD, et al.
Published: (2023-03-01)

Comment on “How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-Risk T1 Colorectal Cancer?”
by: Stanislas Chaussade, MD, PhD, et al.
Published: (2024-06-01)

Comment on “Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multi-Center, Real-World Risk-Matched Analysis”
by: Kilian A. Walter, et al.
Published: (2024-12-01)

Response to Comment on: “Prognostic Relevance of Primary Tumor Sidedness in Early-Stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)”
by: Akira Ouchi, MD, PhD, et al.
Published: (2024-12-01)

Comment on “Birth of a Healthy Baby 9 years after a Surgically Successful Deceased Donor Uterus Transplant”
by: Iori Kisu, MD, PhD, et al.
Published: (2022-06-01)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
by: Liping Zhuang MD, PhD, et al.
Published: (2020-11-01)

Robotic NOTES Hepatectomy
by: Samer Tohme, MD, et al.
Published: (2021-03-01)

Comment on “Celiac Axis Stenosis Is an Underestimated Risk Factor for Increased Morbidity After Pancreatoduodenectomy”
by: Nobuhiro Hasui, MD, PhD, et al.
Published: (2024-12-01)

Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis
by: Shunsuke Fukui MD, et al.
Published: (2024-04-01)

Robotic Full Lobe Hepatectomy With Natural Orifice Extraction
by: Jaime M. Glorioso, MD, et al.
Published: (2021-03-01)

Comment on “Refining Auxiliary Orthotopic Liver Transplantation (AOLT) Improves Outcomes in Adult Patients With Acute Liver Failure”
by: Fabien Robin, M.D., PhD, et al.
Published: (2024-03-01)

The Role of Nonmetastatic Lymph Nodes in the Survival of Colorectal Cancer: A Systematic Review
by: Alexander J. Pennings, MSc, et al.
Published: (2023-12-01)

Comment on: Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Nonfunctional Pancreatic Neuroendocrine Tumors?
by: Mao-Zhen Peng, MD, et al.
Published: (2023-03-01)

Response to: Comment on “Dynamics of Serum CA 19-9 in Patients Undergoing Pancreatic Cancer Resection”
by: Vincent P. Groot, MD, PhD, et al.
Published: (2024-06-01)

High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC
by: Tingting Shen MD, et al.
Published: (2020-03-01)

Comment on: Pancreatectomy With Islet-Autotransplantation As Alternative for Pancreatoduodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out
by: Thomas F. Stoop, MD, et al.
Published: (2023-03-01)

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
by: Binkui Li, MD, PhD, et al.
Published: (2021-06-01)

Comment on: The AI and I: A Collaboration on Competence
by: Martin G. Tolsgaard, MD, PhD, DMSc, et al.
Published: (2023-03-01)

Rapidly Progressive Pulmonary Lymphangitic Carcinomatosis After Liver Transplantation Due to Diffuse Infiltrative Sarcomatoid Hepatocellular Carcinoma
by: Tsukasa Nakamura, MD, PhD, et al.
Published: (2024-03-01)